Cancer News and Research

Latest Cancer News and Research

UK scientists have discovered cancer cells life and death scenario following anti-cancer treatment

CANCER Research UK scientists have discovered how some cancer cells choose to live and others die following anti-cancer treatment, unveiling their findings in the prestigious journal PNAS today.

26 Apr 2004

Give your mum a mammogram for mothers day

This Mother's Day the Pennsylvania Breast Cancer Coalition (PBCC) and Commerce Bank invite you to think of all the women in your life: mothers, grandmothers, aunts, sisters, daughters, and friends.

26 Apr 2004

Students to study compounds shown to prevent cancer drug resistance and studying tomato genes and proteins

Michigan State University’s new Goldwater Scholars for 2004 have a lot of work ahead of them – studying compounds shown to prevent cancer drug resistance and studying tomato genes and proteins.

26 Apr 2004

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

Researchers at Duke University have developed a new analytical approach that combines genetic and clinical data to give cancer patients an individualized prognosis of their cancer recurrence. The information could prove critical in deciding how aggressively to treat the disease following surgery.

26 Apr 2004

New Saint Louis University research sheds light on how obesity occurs

Saint Louis University researchers believe they’ve won a major skirmish in the battle of the bulge, and their findings are published in the May issue of Diabetes.

26 Apr 2004

UK Government ignoring scientific concerns over proposed Human Tissue Bill

The Royal Society today (Monday 26 April 2004) warned the UK Government that continuing to ignore the concerns of the scientific community over the proposed Human Tissue Bill could cut off vital avenues of research into understanding disease.

26 Apr 2004

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

OSI Pharmaceuticals, Inc., Genentech, Inc., and Roche today announced that a Phase III study of Tarceva™ (erlotinib HCl), an investigational HER1/EGFR-inhibitor agent in previously treated patients with non-small cell lung cancer (NSCLC), met its primary endpoint of improving overall survival, with patients receiving Tarceva™ living longer than those in the placebo arm of the study.

26 Apr 2004

Diets like Atkins could help prevent Alzheimer's, cancer, diabetes and Parkinson's disease

Though diets like Atkins and South Beach are the current rage, an emerging eating philosophy may do more than temporarily take off pounds: It could help treat disease.

26 Apr 2004

US airport screening in question after health and screening issues

Security screeners at Miami International Airport have become ill for the fourth time in a single month.

25 Apr 2004

The cancer death rate for African-American males would drop by nearly two-thirds if their exposure to tobacco smoke was eliminated

The overall cancer death rate for African-American males would drop by nearly two-thirds -- without any other intervention -- if their exposure to tobacco smoke was eliminated, a new study suggests.

25 Apr 2004

Severe Acute Respiratory Syndrome (SARS) overview

Severe Acute Respiratory Syndrome (SARS) is an atypical form of pneumonia that first appeared in November 2002 in Guangdong Province, China.

24 Apr 2004

Health Canada prepares for West Nile virus

To prepare for the upcoming West Nile (WN) virus season, Health Canada, in collaboration with its many partners, is focussing its efforts in six main areas of activity

24 Apr 2004

Skin cancer is now the UK's most common cancer in both men and women

Macmillan skin cancer nurse specialists will be promoting sun awareness and the dangers of skin cancer during Sun Awareness Week which runs from 10 to 16 May.

23 Apr 2004

Leading cancer care charity Macmillan Cancer Relief is once again rated most effective charity at campaigning by MPs

Leading cancer care charity Macmillan Cancer Relief is once again rated most effective charity at campaigning by MPs. The latest nfpSynergy Charity Parliamentary Monitor puts Macmillan ahead of the UK's other leading charities.

23 Apr 2004

Dance Marathon to commit $10 million for new pediatric cancer pavilion

The 2004 Overall Committee for the Penn State IFC/Panhellenic Dance Marathon (THON) has announced that THON will commit $10 million over the next six years to create a pediatric cancer pavilion at Children's Hospital at Penn State Milton S. Hershey Medical Center.

23 Apr 2004

CellCept linked to reduced cancer incidence

A study presented today at an international transplant meeting showed that heart transplant patients treated with the immunosuppressant CellCeptÒ (mycophenolate mofetil) in standard immunosuppressive regimens had a significantly lower risk of developing cancer compared to those receiving non-CellCept-based treatment regimens.

23 Apr 2004

The April 2004 issue of Otolaryngology focuses on head and neck surgery

The efficacy of a new cancer-fighting virus is tested in the study, “Treatment of Solid Sarcomas in Immunocompetent Mice with Novel Oncolytic Herpes Simplex Viruses.” A team of multi-disciplinary Japanese researchers found that a weakened version of herpes simplex virus (HSV) effectively eradicated neck and flank tumors in mice.

23 Apr 2004

Palliative care improvements needed in Australia

While Australian expertise in palliative care to ease the suffering of dying people has developed rapidly over the past 20 years, there is still a long way to go, writes Professor Margaret O'Connor, who holds the inaugural Vivian Bullwinkel chair in palliative care nursing at Monash.

23 Apr 2004

Researchers make millions upon millions of drug-like peptides quickly and efficiently

Two Johns Hopkins scientists have figured out a simple way to make millions upon millions of drug-like peptides quickly and efficiently, overcoming a major hurdle to creating and screening huge "libraries" of these super-short proteins for use in drug development.

23 Apr 2004

Hepatitis B vaccination for inmates

rrectional settings provide a unique opportunity to offer hepatitis B vaccination to a substantial number of high-risk adults who are willing to be vaccinated and who would not otherwise have access to the preventive medicine, according to a new Brown University study of inmates within the Rhode Island Department of Corrections.

23 Apr 2004

Cancer News and Research

Latest Cancer News and Research

UK scientists have discovered cancer cells life and death scenario following anti-cancer treatment

Give your mum a mammogram for mothers day

Students to study compounds shown to prevent cancer drug resistance and studying tomato genes and proteins

New analytical approach that combines genetic and clinical data to give individualized prognosis of cancer recurrence

New Saint Louis University research sheds light on how obesity occurs

UK Government ignoring scientific concerns over proposed Human Tissue Bill

New cancer drug Tarceva - a breakthrough with significant survival benefit in patients with advanced lung cancer

Diets like Atkins could help prevent Alzheimer's, cancer, diabetes and Parkinson's disease

US airport screening in question after health and screening issues

The cancer death rate for African-American males would drop by nearly two-thirds if their exposure to tobacco smoke was eliminated

Severe Acute Respiratory Syndrome (SARS) overview

Health Canada prepares for West Nile virus

Skin cancer is now the UK's most common cancer in both men and women

Leading cancer care charity Macmillan Cancer Relief is once again rated most effective charity at campaigning by MPs

Dance Marathon to commit $10 million for new pediatric cancer pavilion

CellCept linked to reduced cancer incidence

The April 2004 issue of Otolaryngology focuses on head and neck surgery

Palliative care improvements needed in Australia

Researchers make millions upon millions of drug-like peptides quickly and efficiently

Hepatitis B vaccination for inmates

Understanding the DNA Damage Response in Innate Immunity eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in